发明名称 CASPASE-HEMMER
摘要 The present invention relates to an isoxazoline derivative of formula (I), the pharmaceutically acceptable salts, esters and stereochemically isomeric forms thereof, and the use of the derivative in inhibiting the activity of caspases. The present invention also relates to a pharmaceutical composition for preventing inflammation and apotosis which comprises the isoxazoline derivative, pharmaceutically acceptable salts, esters and stereochemically isomeric forms thereof and the process for preparing the same. The derivative according to the present invention can be effectively used in treating diseases due to caspases, such as, for example the disease in which cells are abnormally died, dementia, cerebral stroke, AIDS, diabetes, gastric ulcer, hepatic injure by hepatitis, sepsis, organ transplantation rejection reaction and anti-inflammation.
申请公布号 DE60013147(D1) 申请公布日期 2004.09.23
申请号 DE2000613147 申请日期 2000.09.18
申请人 LG CHEM INVESTMENT, LTD. 发明人 KIM, EUN-KYEONG;PARK, MI-JEONG;LEE, TAE-HEE;CHANG, HYE-KYUNG;PARK, TAE-KYO;KANG, CHANG-YUIL;KIM, YOUNG-MYEONG;MOON, KWANG-YUL;OH, YOUNG-LEEM;MIN, CHANG-HEE;CHUNG, HYUN-HO
分类号 C07D261/04;A61K31/42;A61K31/422;A61K31/454;A61K31/4709;A61K31/4725;A61P1/04;A61P1/16;A61P3/10;A61P9/00;A61P9/10;A61P19/02;A61P25/28;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P31/20;A61P37/00;A61P37/02;A61P43/00;C07B61/00;C07D261/18;C07D413/12;C07D413/14;C07D521/00;(IPC1-7):A61K31/42;C07C233/61;A61K31/470;A61K31/472 主分类号 C07D261/04
代理机构 代理人
主权项
地址